Chronic Disease Management Market size to grow by USD 4,610.51 million from 2022 to 2027|Increasing prevalence of chronic diseases to drive the market growth - Technavio

NEW YORK, July 5, 2023 /PRNewswire/ -- The chronic disease management market size is set to grow by USD 4,610.51 million from 2022 to 2027 and register a CAGR of 11.09%, according to Technavio's latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio's reports present a detailed study by way of synthesis, and summation of data from multiple sources. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Technavio offers an up-to-date analysis regarding the current global market scenario and the overall market environment. View Sample Report

The report also covers the following areas:

• Chronic Disease Management Market size
• Chronic Disease Management Market trends
• Chronic Disease Management Market industry analysis

Chronic Disease Management Market 2023-2027: Segmentation

The chronic disease management market is segmented as follows:

• Type 
• Solutions
• Services
• End-user 
• Healthcare Providers
• Healthcare Payers
• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

The market share growth by the solutions segment will be significant for market growth during the forecast period. The growth of the global chronic disease management market can be attributed to the increase in awareness about the use of cloud-based and on-premises solutions in healthcare. Furthermore, the demand for shorter hospital stays has increased, which lowers the cost incurred in hospitalization, which, in turn, has increased the demand for chronic disease management solutions. Hence, such factors drive the growth of the segment during the forecast period.

Detailed insights on the impact of each segment and make informed business decisions, request a sample report!

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Some of the major vendors of the chronic disease management market include ALLSCRIPTS HEALTHCARE SOLUTIONS INC., Cedar Gate Technologies, cliexa Inc., Cognizant Technology Solutions Corp., Epic Systems Corp., ExlService Holdings Inc., Health Care Service Corp., Health Catalyst Inc., HealthEdge Software Inc., Hinduja Global Solutions Ltd., Infosys Ltd., Koninklijke Philips NV, MINES and Associates Inc., NextGen Healthcare Inc., Pegasystems Inc., ScienceSoft USA Corp., Vivify Health Inc., WellSky Corp., ZeOmega Inc., and Zyter Inc.. To help businesses improve their market position, Technavio's report provides a detailed analysis of around 15+ vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. Backed with competitive intelligence and benchmarking, our research reports on the chronic disease management market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.
Vendor Offerings

• ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - The company offers Chronic Care Management Program features services to assist care providers in reducing the complexity of caring for chronic patients, including the creation of a care plan, medication reconciliation, scheduling of preventive care services, and patient outreach.
• Cedar Gate Technologies - The company offers chronic disease management, such as the Care Management application, which is clinically driven and powers workflows for utilization management, case management, condition management, prevention, and wellness, all through a centralized member dashboard.
• cliexa Inc. - The company offers Chronic Care Management which is the series of actions taken by health care professionals and clinicians to improve the lives of patients with chronic diseases, including conditions such as Alzheimer's disease, asthma, cancer, cardiovascular disease, COPD, depression, infectious diseases, rheumatoid arthritis, and more.

Chronic Disease Management Market 2023-2027: Market Dynamics

Key Drivers

The increasing prevalence of chronic diseases drives the growth of the chronic disease management market. There is a rapid increase in infectious and chronic diseases such as cancer and diabetes is increasing across the world. Furthermore, the rising incidence of diseases such as diabetes and cancer is increasing the need for chronic disease management solutions and services. 

For example, according to the National Center for Biotechnology Information (NCBI), chronic diseases account for around 43% of the global disease burden and 60% of deaths across the world. Hence, such factors drive the growth of the market.

Significant Trends

Technological advancement in the global chronic disease management market is an emerging trend influencing market growth. Market players adopt advanced technologies such as AI to treat chronic diseases.  Moreover, medical personnel can use AI for early intervention and improved outcomes for patients with diabetes, heart disease, and cancer.

In February 2022, Biofourmis introduced Bioformis Care, a service that provides high-quality remote care to patients with chronic diseases. Hence, such trends boost the growth of the chronic disease management market during the forecast period.

Major Challenges

Rising medical data privacy concerns challenge the growth of the chronic disease management market during the forecast period. Advanced technologies are used to store, process, analyze, and interpret medical documents. But the use of such technologies leads to data privacy concerns.

Also, according to the privacy laws of various countries, personal data, medical records, and medication information of any person should not be disclosed without authorization and permission. Hence, such challenges impede market growth during the forecast period.

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - Buy the report!

Chronic Disease Management Market 2023-2027: Key Highlights

• CAGR of the market during the forecast period 2023-2027
• Detailed information on factors that will assist chronic disease management market growth during the next five years
• Estimation of the chronic disease management market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the chronic disease management market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of chronic disease management market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:
The chronic obstructive pulmonary disease drugs market is estimated to grow at a CAGR of 6.09% between 2022 and 2027. The chronic obstructive pulmonary disease drug market size is forecast to increase by USD 6,654.49 million. This market report extensively covers market segmentation by product (combination therapy and monotherapy), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and geography (North America, Europe, Asia, and Rest of World (ROW)). The increasing prevalence of COPD is accelerating the growth of the chronic obstructive pulmonary disease drug market globally.

The chronic myelogenous leukemia (CML) therapeutics market size is expected to increase by USD 2.14 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.1%. Furthermore, this report extensively covers chronic myelogenous leukemia therapeutics market segmentation by product (targeted therapy, chemotherapy, and immunotherapy) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The strategic alliances are notably driving the chronic myelogenous leukemia therapeutics market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global chronic disease management market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on global chronic disease management market 2017 - 2021 ($ million)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.3 End user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – End user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments 
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

• 6.2 Comparison by Type 
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Solutions - Market size and forecast 2022-2027
• Exhibit 34: Chart on Solutions - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Solutions - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Solutions - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Solutions - Year-over-year growth 2022-2027 (%)

• 6.4 Services - Market size and forecast 2022-2027
• Exhibit 38: Chart on Services - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Services - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Services - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Services - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Type 
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user

• 7.3 Healthcare providers - Market size and forecast 2022-2027 
• Exhibit 48: Chart on Healthcare providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Healthcare providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Healthcare providers - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Healthcare providers - Year-over-year growth 2022-2027 (%)

• 7.4 Healthcare payers - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Healthcare payers - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Healthcare payers - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Healthcare payers - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Healthcare payers - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by End-user 
• Exhibit 56: Market opportunity by End-user ($ million)
• Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 83: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.11 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 99: Market opportunity by geography ($ million)
• Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 103: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 105: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 106: Matrix on vendor position and classification

• 12.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
• Exhibit 107: ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - Overview
• Exhibit 108: ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - Business segments
• Exhibit 109: ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - Key news
• Exhibit 110: ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - Key offerings
• Exhibit 111: ALLSCRIPTS HEALTHCARE SOLUTIONS INC. - Segment focus

• 12.4 Cedar Gate Technologies 
• Exhibit 112: Cedar Gate Technologies - Overview
• Exhibit 113: Cedar Gate Technologies - Product / Service
• Exhibit 114: Cedar Gate Technologies - Key offerings

• 12.5 cliexa Inc. 
• Exhibit 115: cliexa Inc. - Overview
• Exhibit 116: cliexa Inc. - Product / Service
• Exhibit 117: cliexa Inc. - Key offerings

• 12.6 Epic Systems Corp. 
• Exhibit 118: Epic Systems Corp. - Overview
• Exhibit 119: Epic Systems Corp. - Product / Service
• Exhibit 120: Epic Systems Corp. - Key offerings

• 12.7 Health Catalyst Inc. 
• Exhibit 121: Health Catalyst Inc. - Overview
• Exhibit 122: Health Catalyst Inc. - Business segments
• Exhibit 123: Health Catalyst Inc. - Key offerings
• Exhibit 124: Health Catalyst Inc. - Segment focus

• 12.8 HealthEdge Software Inc. 
• Exhibit 125: HealthEdge Software Inc. - Overview
• Exhibit 126: HealthEdge Software Inc. - Key offerings

• 12.9 Infosys Ltd. 
• Exhibit 127: Infosys Ltd. - Overview
• Exhibit 128: Infosys Ltd. - Business segments
• Exhibit 129: Infosys Ltd. - Key news
• Exhibit 130: Infosys Ltd. - Key offerings
• Exhibit 131: Infosys Ltd. - Segment focus

• 12.10 Koninklijke Philips NV 
• Exhibit 132: Koninklijke Philips NV - Overview
• Exhibit 133: Koninklijke Philips NV - Business segments
• Exhibit 134: Koninklijke Philips NV - Key news
• Exhibit 135: Koninklijke Philips NV - Key offerings
• Exhibit 136: Koninklijke Philips NV - Segment focus

• 12.11 MINES and Associates Inc. 
• Exhibit 137: MINES and Associates Inc. - Overview
• Exhibit 138: MINES and Associates Inc. - Product / Service
• Exhibit 139: MINES and Associates Inc. - Key offerings

• 12.12 NextGen Healthcare Inc. 
• Exhibit 140: NextGen Healthcare Inc. - Overview
• Exhibit 141: NextGen Healthcare Inc. - Product / Service
• Exhibit 142: NextGen Healthcare Inc. - Key offerings

• 12.13 Pegasystems Inc. 
• Exhibit 143: Pegasystems Inc. - Overview
• Exhibit 144: Pegasystems Inc. - Product / Service
• Exhibit 145: Pegasystems Inc. - Key news
• Exhibit 146: Pegasystems Inc. - Key offerings

• 12.14 ScienceSoft USA Corp. 
• Exhibit 147: ScienceSoft USA Corp. - Overview
• Exhibit 148: ScienceSoft USA Corp. - Product / Service
• Exhibit 149: ScienceSoft USA Corp. - Key offerings

• 12.15 Vivify Health Inc. 
• Exhibit 150: Vivify Health Inc. - Overview
• Exhibit 151: Vivify Health Inc. - Product / Service
• Exhibit 152: Vivify Health Inc. - Key offerings

• 12.16 WellSky Corp. 
• Exhibit 153: WellSky Corp. - Overview
• Exhibit 154: WellSky Corp. - Product / Service
• Exhibit 155: WellSky Corp. - Key offerings

• 12.17 ZeOmega Inc. 
• Exhibit 156: ZeOmega Inc. - Overview
• Exhibit 157: ZeOmega Inc. - Product / Service
• Exhibit 158: ZeOmega Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 159: Inclusions checklist
• Exhibit 160: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 161: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 162: Research methodology
• Exhibit 163: Validation techniques employed for market sizing
• Exhibit 164: Information sources

• 13.5 List of abbreviations 
• Exhibit 165: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio